Rabies veterinary concentrated bulk antigen -inactivated
Product Description
Indian Immunologicals Ltd
-
Country/Region:India
-
On CPHI since:2019
-
Employees:1000 - 4999
Company types
Categories
Indian Immunologicals Ltd
-
Country/Region:India
-
On CPHI since:2019
-
Employees:1000 - 4999
Company types
More Products from Indian Immunologicals Ltd (56)
-
Product Oxfendazole 150mg
Broad spectrum anthelmintic against Lungworms, Roundworms and Tapeworms -
Product Oxfendazole 2200mg
Broad spectrum anthelmintic against Lungworms, Roundworms and Tapeworms -
Product Oxfendazole 2500mg
Broad spectrum anthelmintic against Lungworms, Roundworms and Tapeworms -
Product Posi-FMD
Each dose contains: monovalent FMD inactivated antigens of O strain adsorbed on to aluminium hydroxide gel. Mineral oil added as adjuvant thiomersal B.P as preservative ≤ 0.02% w/v, phosphate buffer diluent q.s -
Product Prazital Forte (Praziquintal , Fenbendazole and Pyrantel Parmate
Prazital is a formidable combination of Praziquantel and Pyrantel Pamoate and it offers assured elimination of roundworms, hookworms, ascarides and tapeworms. -
Product Rabisure
Each 1mL contains: inactivayted rabies viral antigen of potency ≥1.0IU [rabies virus strain CVS propagated on BHK cells ] adsorbed on to aluminium hydroxide gel, thiomersal B.P as preservative ≤0.02% w/v, phosphate buffer diluent q.s to 1mL -
Product Raksha -BT
blue tongue vaccine, inactivated Each dose (2mL) contains: BTV-01 strain (mean antibody titre ≥ 1:20) , BTV-02 strain (mean antibody titre ≥ 1:20), BTV-10 strain (mean antibody titre ≥ 1:20), BTV-16 strain (mean antibody titre ≥ 1:20), BTV-23 strain (mean antibody titre ≥ 1:20), sodium thiosulphate solut... -
Product Raksha bivalent
Each dose contains: bivalent FMD inactivated antigens of O and A strains adsorbed on to aluminium hydroxide gel. Saponin added as adjuvant chlorofom B.P as preservative 0.015mL, phosphate buffer diluent q.s -
Product Raksha HS + BQ Haemorrhagic Septicaemia + Black Quarter vaccine
Raksha-HS+BQ vaccine contains formalin inactivated cultures of Pasteurella multocida and Clostridium chauvoei adjuvanted with aluminium hydroxide gel -
Product Raksha Ovac Bivalent
Each dose contains: bivalent FMD inactivated antigens of O and Asia-1 strains adsorbed on to aluminium hydroxide gel. Mineral oil added as adjuvant thiomersal B.P as preservative ≤ 0.02% w/v, phosphate buffer diluent q.s -
Product Raksha Ovac Monovalent
Each dose contains: monovalent FMD inactivated antigens of Asia-1 strain adsorbed on to aluminium hydroxide gel. Mineral oil added as adjuvant thiomersal B.P as preservative ≤ 0.02% w/v, phosphate buffer diluent q.s
Indian Immunologicals Ltd resources (10)
-
Brochure IIL Contract manufacturing brochure
Indian Immunologicals limited also has a state of the art facility located in Genome Valley for oral solid dosage forms and injectable (small volume parenteral). With sufficient plant capacities, we can offer contract manufacturing services for the same. -
Brochure Cysvax
Cysvax is a bio technologically derived immunological veterinary vaccine. The vaccine is first of its kind in the world and is used for immunization of pigs against Porcine cysticercosis. Cysvax is available in 1 mL, 5mL, 10mL and 20mL packs. -
Brochure Human Health vaccine brochure
The brochure gives detailed information about the Human health vaccines that are offered by IIL for export purpose. -
Brochure Animal health product brochure
The brochure gives an overview about the Animal health product portfolio of IIL. It primarily includes vaccines as well as formulations. -
Brochure Corporate Brochure
IIL Corporate Brochure -
Brochure Animal Health Products
List of IIL's Animal Health Vaccines and Formulations -
Brochure Human Health Products
List of IIL's Human Health Products -
Brochure IIL Technical Capabilities
Brochure outlining IIL's technical capabilities. -
Whitepaper Interview with Dr K Anand Kumar, Managing director of Indian Immunologicals Limited
An interview with Dr K Anand Kumar, Managing director, Indian Immunologicals Limited regarding the company's future growth plans & current R&D pipeline.
